ArticleCancers2021

Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.

Kim L Clar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.